title: Can CYP3A activity be evaluated for drug interaction using a nanogram dose of probe drug?
authors: Clinical Pharmacology, Medical & Scientific Affairs, Asubio Pharmaceuticals, Edison, New Jersey, USA.
authors: C
authors: C
authors: Oo
authors: Clinical Pharmacology, Medical & Scientific Affairs, Asubio Pharmaceuticals, Edison, New Jersey, USA.
authors: K L
authors: KL
authors: Duchin
mesh_terms: D051544:Cytochrome P-450 CYP3A / Q000235:genetics* / Q000378:metabolism*; D005260:Female; D006801:Humans; D007654:Ketoconazole / Q000494:pharmacology*; D008297:Male; D008874:Midazolam / Q000008:administration & dosage* / Q000494:pharmacology*
chemical_list: D051544:Cytochrome P-450 CYP3A; D008874:Midazolam; D007654:Ketoconazole